Topokine therapeutics
WebThe cream XAF5 Ointment was developed by Topokine Therapeutics but was recently acquired by Allergan may make blepharoplasty a thing of the past. The proprietary active ingredient of XAF5 penetrates into the fat to shrink the size of the fat cells in under-eye bags. If XAF5 Ointment eventually makes it way to market, it would be the first ... WebMar 23, 2024 · Biotechnology company Topokine Therapeutics has initiated a Phase 2b/3 study of its lead product, XAF5 Ointment, for the reduction of steatoblepharon (undereye …
Topokine therapeutics
Did you know?
WebApr 21, 2016 · Under the terms of the agreement, Allergan acquired Topokine Therapeutics for an upfront payment of $85 million and success-based development and sales … WebApr 22, 2016 · Allergan has acquired Topokine Therapeutics for an upfront payment of $85 million and success-based development and sales milestones for XAF5. Topokine is a privately held, clinical-stage biotechnology company focused on developing topical medicines for fat reduction. XAF5 is a first-in-class topical agent in late-stage …
WebExplore {Topokine Therapeutics's key management people. Discover current leadership team members including founders, CEO, other executives and board directors. Topokine … WebMar 31, 2024 · About Topokine Topokine Therapeutics is a clinical-stage biotechnology company developing topical prescription medications for non-invasive contouring of the face and body. The company's lead program, XAF5 Gel, is a topical adipomodulatory product in Phase 2 clinical development for local reduction of excess subcutaneous fat.
WebAbout Us. Sage is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. … WebMar 1, 2013 · Age: 39 • Silver Spring, Maryland. President and CEO, Topokine Therapeutics. Murat Kalayoglu's career springs from the heart of the Wisconsin Idea — or maybe from its liver. A founder of HealthHonors Corporation and now president and CEO of Topokine Therapeutics, Kalayoglu has done research at Harvard and now lives outside Washington, …
http://topokinetherapeutics.com/
WebMar 12, 2013 · Topokine Therapeutics is a clinical-stage biotechnology company developing therapies for dermatology and medical aesthetics. The company's lead program, XAF5 … girl scout snacks badgeWebApr 22, 2016 · Allergan has acquired Topokine Therapeutics for $85 million upfront in a deal that expands the buyer’s cosmetic drugs pipeline with Topokine’s Phase IIb/III candidate … funeral homes armuchee gaWebTopokine Therapeutics, Inc., a clinical-stage biotechnology company, develops topical prescription medications that act pharmacologically on adipocytes to contour the face and body non-invasively. Its lead product, XAF5 Ointment, is in Phase-2 clinical development for the reduction of excess eyelid fat (steatoblepharon) and other indications. girl scouts napa caWebMar 12, 2013 · Topokine Therapeutics is a clinical-stage biotechnology company developing therapies for dermatology and medical aesthetics. The company's lead program, XAF5 Gel, is a skin cream being developed ... girl scout snack badgeWebMar 16, 2015 · Seeing the possibilities, they started a company called Topokine Therapeutics and developed a nonirritating ointment using the same molecule that was in the eye drops. Because of the ointment's ... girl scout snack ideasWebMichael Singer, MD, PhD, is a serial entrepreneur, investor, and ophthalmologist. He has co-founded several life sciences companies, including HealthHonors (sold to Healthways in … funeral homes around albers illinoisWeb00000000000. US-9820993-B2. Methods and compositions for topical delivery of prostaglandins to subcutaneous fat. Active. 15-May-2013. A61K31/5575. 00. To view Topokine’s complete patent history, request access ». girl scout snack badge ideas